Tilak, Novartis to collaborate on promotion of remote vision monitoring technology
Tilak Healthcare and Novartis have partnered to internationally promote Tilak’s mobile app for remote vision monitoring, according to a press release.
OdySight is available by prescription and employs puzzles to increase patient engagement, the release said.
“We are pleased to embark on this journey alongside Novartis Pharma AG, which has a long history of providing innovative solutions for patients. Thanks to this partnership, Tilak Healthcare will make OdySight accessible to a lot more people and will help optimize the current health care process. The current exceptional circumstances reinforce our belief in the usefulness of clinically validated digital tools for optimizing remote patient monitoring and building tomorrow’s health care system,” Edouard Gasser, CEO of Tilak Healthcare, said in the release.
Tilak and Novartis France launched a joint promotion for OdySight in 2019.